Deerfield International Master Fund, L.P., 10% Owner at Vanda Pharmaceuticals Inc. (VNDA), sold 1,120,461 shares at $16.24 ($18.6M) on 2016-09-22, disclosed to the SEC on 2016-09-26.
Open-market sale of $18.6M VNDA by 10% Owner. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $16.24 | 68,940 | $1.1M | 6.0% |
| 2 | $16.24 | 119,690 | $1.9M | 10.5% |
| 3 | $16.24 | 152,334 | $2.5M | 13.3% |
| 4 | $16.71 | 157,607 | $2.6M | 14.2% |
| 5 | $16.71 | 273,632 | $4.6M | 24.6% |
| 6 | $16.71 | 348,258 |
| $5.8M |
| 31.4% |
| Total | $16.57 avg | 1,120,461 | $18.6M | 100% |
| Filing → |
| EHTH | SELL | 2016-06-08 | $488K | — | Filing → |
| ZFGN | BUY | 2016-02-17 | $177K | — | Filing → |
| XNPT | BUY | 2016-02-16 | $18.8M | — | Filing → |